Metraipolis › archive › dc_fabb736395a3

Outcomes of belatacept-based quadruple immunosuppression therapy in kidney transplant recipients with persistent alloimmune response: a single-center… — Europe PMC PMID:42396448

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42396448
DOI
10.3389/fimmu.2026.1844666
License (as archived)
solo-consultazione
Archived
2026-10-28T03:03:07.272Z
SHA-256 of the archived text
ac63bae074b6e94508327dceb8a94cbe3f3e47519f5f2c070ae88ed5788670c5
Stable URL of this page
https://metraipolis.com/documento/dc_fabb736395a3

How to cite

Outcomes of belatacept-based quadruple immunosuppression therapy in kidney transplant recipients with persistent alloimmune response: a single-center… — Europe PMC PMID:42396448 — Europe PMC (en), https://europepmc.org/article/MED/42396448 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fabb736395a3 (Metraipolis archive dc_fabb736395a3, sha256 ac63bae074b6e94508327dceb8a94cbe3f3e47519f5f2c070ae88ed5788670c5)
BibTeX
@misc{dcfabb736395a3,
  title = {Outcomes of belatacept-based quadruple immunosuppression therapy in kidney transplant recipients with persistent alloimmune response: a single-center… — Europe PMC PMID:42396448},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42396448},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fabb736395a3; sha256 ac63bae074b6e94508327dceb8a94cbe3f3e47519f5f2c070ae88ed5788670c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42396448. Agents can read the archived copy with the MCP tool read_document.